Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 07, 2026, titled "Intimation of Earnings call".
View original source (NSE India)
Earlier from Dr. Reddy's Laboratories
- Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
- Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026
- Dr. Reddy's Laboratories Ltd. Press Release Jul 23 2026
- Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026